Complement deficiency
MONDO:0003832A genetic deficiency of any of the component of the complement system (including the classical, alternative, and terminal pathway components), that can either be acquired or inherited.
Also known as: complement activation disease, complement deficiency, disorder of complement activation, immunodeficiency due to a complement cascade component deficiency
68 clinical trials for this condition and its sub-types, 2 tagged with Complement deficiency itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Complement deficiency
-
Atypical hemolytic-uremic syndrome 19 trials
4 sub-types
-
Classic complement early component deficiency 0 trials · 7 incl. sub-types
13 sub-types
- C1 inhibitor deficiency 5 trials
- Complement component 3 deficiency 2 trials
- Complement component 2 deficiency 0 trials
- Complement component 4a deficiency 0 trials
- Complement component 4b deficiency 0 trials
- Complement component 5 deficiency 0 trials
- Complement component 6 deficiency 0 trials
- Complement component 7 deficiency 0 trials
- Complement component 9 deficiency 0 trials
- Complement component C1r/C1s deficiency 0 trials
- Complement component C1s deficiency 0 trials
- Type I complement component 8 deficiency 0 trials
- Type II complement component 8 deficiency 0 trials
-
Disorder of lectin complement activation pathway 0 trials · 1 incl. sub-types
3 sub-types
-
Complement factor I deficiency 0 trials
-
Complement receptor deficiency 0 trials
-
6 sub-types
- C1Q deficiency 0 trials Sub-types →
- Complement component 2 deficiency 0 trials
- Complement component 4a deficiency 0 trials
- Complement component 4b deficiency 0 trials
- Complement component C1r/C1s deficiency 0 trials
- Complement component C1s deficiency 0 trials
-
6 sub-types
- Complement component 5 deficiency 0 trials
- Complement component 6 deficiency 0 trials
- Complement component 7 deficiency 0 trials
- Complement component 9 deficiency 0 trials
- Type I complement component 8 deficiency 0 trials
- Type II complement component 8 deficiency 0 trials
Most studied deeper sub-types
-
Could a daily pill stop hereditary angioedema attacks?
Disease control Stopped earlyThis trial tests whether an experimental oral medication, deucrictibant, can reduce the number of swelling attacks in people with hereditary angioedema (HAE) types I and II. Participants take either a low or high dose of the drug or a placebo for 12 weeks, and then may continue o…
Phase 2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Promising aHUS drug trial stalls after only 6 patients enrolled
Disease control Stopped earlyThis study tested a drug called narsoplimab (OMS721) for atypical hemolytic uremic syndrome (aHUS), a rare condition that causes blood clots and organ damage. The trial aimed to see if the drug could improve platelet counts and was safe for adults and adolescents. However, the st…
Phase 3 • Sponsor: Omeros Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC